Why Is Amyloid-β PET Requested After Performing CSF Biomarkers?

BACKGROUND: Amyloid-β positron emission tomography (PET) and cerebrospinal fluid (CSF) Aβ(42) are considered interchangeable for clinical diagnosis of Alzheimer’s disease. OBJECTIVE: To explore the clinical reasoning for requesting additional amyloid-β PET after performing CSF biomarkers. METHODS: W...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Alzheimers Dis
Päätekijät: Reimand, Juhan, Groot, Colin, Teunissen, Charlotte E., Windhorst, Albert D., Boellaard, Ronald, Barkhof, Frederik, Nazarenko, Sergei, van der Flier, Wiesje M., van Berckel, Bart N.M., Scheltens, Philip, Ossenkoppele, Rik, Bouwman, Femke
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: IOS Press 2020
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7081099/
https://ncbi.nlm.nih.gov/pubmed/31796674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-190836
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia